Annual report
2112.TEDINET S100OJNL
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥25.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥23.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥25.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥807m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥982m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥775m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥776m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥840m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥906m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥775m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥26.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥27.2bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥24.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.9bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥17.3bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.9bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.9bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥8.8bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥8.3bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.9bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.8bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥792m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥711m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥481m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥602m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥554m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥595m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥456m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥629m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥22.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.58 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.65 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.45 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥381.21 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥365.4 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥328.42 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥325.01 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥306.4 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 39.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.4% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.3% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.3% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 82 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 80 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 87 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 90 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 88 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥18.0bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥17.8bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥18.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥19.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥20.1bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥539m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥825m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥595m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥850m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥952m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥742m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥595m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥844m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥395m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥585m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥657m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥749m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥514m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥24.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥25.9bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥23.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.9bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥14.9bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥16.7bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.4bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥8.4bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.0bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥14.55 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.59 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.27 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.66 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.97 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥348.28 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥339.76 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥310.17 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥308.63 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥293.49 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 38.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.6% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.2% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.6% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.6% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 35,000,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,000,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,000,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,000,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,000,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 45 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 51 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 50 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 52 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 47 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 74
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥1m |
| Otherother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥21m |
| Otherother segments | employees | at 2022-03-31 | 2 pure |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥133m |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥117m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥16m |
| Otherother segments | segment assets | at 2022-03-31 | ¥1.1bn |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥59m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥72m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥75m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥75m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥10.2bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1.1bn |
| Biotechnologyreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥22m |
| Biotechnologyreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥61m |
| Biotechnologyreportable segment | employees | at 2022-03-31 | 9 pure |
| Biotechnologyreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Biotechnologyreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Biotechnologyreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥30m |
| Biotechnologyreportable segment | segment assets | at 2022-03-31 | ¥1.6bn |
| Biotechnologyreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥491m |
| Sugarreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥282m |
| Sugarreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥499m |
| Sugarreportable segment | employees | at 2022-03-31 | 43 pure |
| Sugarreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥23.2bn |
| Sugarreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥23.2bn |
| Sugarreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥28m |
| Sugarreportable segment | segment assets | at 2022-03-31 | ¥13.2bn |
| Sugarreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥307m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥582m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥25.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥25.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥75m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥15.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.9bn |
| Otherother segments | capex | 2020-04-01 → 2021-03-31 | ¥2m |
| Otherother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥21m |
| Otherother segments | revenue | 2020-04-01 → 2021-03-31 | ¥135m |
| Otherother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥114m |
| Otherother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥21m |
| Otherother segments | segment assets | at 2021-03-31 | ¥1.1bn |
| Otherother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥60m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥15m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥75m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥78m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥11.6bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥1.3bn |
| Biotechnologyreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥53m |
| Biotechnologyreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥62m |
| Biotechnologyreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.9bn |
| Biotechnologyreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.9bn |
| Biotechnologyreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥30m |
| Biotechnologyreportable segment | segment assets | at 2021-03-31 | ¥1.7bn |
| Biotechnologyreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥382m |
| Sugarreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥371m |
| Sugarreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥504m |
| Sugarreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥21.7bn |
| Sugarreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥21.7bn |
| Sugarreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥26m |
| Sugarreportable segment | segment assets | at 2021-03-31 | ¥12.8bn |
| Sugarreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥427m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥588m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥23.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥23.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥2.3bn |
| Otherother segments | employees | at 2022-03-31 | 1 pure |
| Biotechnologyreportable segment | employees | at 2022-03-31 | 9 pure |
| Sugarreportable segment | employees | at 2022-03-31 | 8 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,437
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | CurrentYearInstant | 26114000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 306.40 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 325.01 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 328.42 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 365.40 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 381.21 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 33.45 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 31.00 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 28.65 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 28.58 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 22.43 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.333 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.360 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.363 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.364 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.397 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.114 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.098 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.088 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.082 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.060 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 7.9 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 7.5 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 6.8 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 9.1 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 9.4 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 1901000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 1959000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 1184000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 792000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 1082000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -595000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -554000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -602000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -481000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -711000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -629000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -1523000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 456000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 1880000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -1738000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 1784000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 1667000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 2705000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 4897000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |